Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen(196170) Designated as Short Selling Overheated Stock… Short Selling Banned on Jan 22

Posted on January 21, 2026July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen(196170) Designated as Short Selling Overheated Stock… Short Selling Banned on Jan 22

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2026-01-21

Disclosure Type: Designation as Short Selling Overheated Stock (Short Selling Ban Applied)

💡 3-Second Summary

Alteogen has been designated as a short selling overheated stock under Kosdaq market regulations, resulting in a total ban on short selling transactions in both the regular and after-hours markets on January 22, 2026.

📊 1. [Key Disclosure Content & Summary of Major Figures]

  • Target Stock: Alteogen (Ticker: KR7196170005)
  • Designation Date (Ban Effective Date): January 22, 2026 (For 1 day)
  • Measures Taken: Short selling transactions for this stock are strictly prohibited in the regular market and after-hours market on the designated date. Short selling will be permitted again from the day following the designation date.
  • Extension Condition: If the stock price declines by -5% or more on the day of the short selling ban (January 22), the short selling ban period may be extended.
  • Exceptions: Short selling is exceptionally permitted for liquidity providing quotes (LP), market making quotes, hedge trading for ELW, ETF, and ETN products, and hedge trading for market making in the derivatives market.
  • Other Notes: If the stock is already suspended from trading on the designation date, no separate measures will be taken regarding this designation.

📈 2. [Expert View: What This Disclosure Means for Investors]

  • Potential Supply-Demand Impact: The designation as a short selling overheated stock indicates a recent abnormal surge in short selling volume for the stock. Since new short positions are restricted on the designated date, downward pressure resulting from short selling could temporarily ease in the short term.
  • Monitoring Volatility Risks: While short selling is banned for one day, investors should remain cautious as the ban period could be extended if the stock price drops by -5% or more on that day. Additionally, it is important to note that certain short selling volumes may still occur under the specified regulatory exceptions (such as liquidity provision and hedging).
  • Investor Interpretation: This measure does not signify any structural change in the company’s underlying business value or financial fundamental; rather, it is a technical market-stabilizing intervention reacting to supply-demand overheating. Therefore, instead of interpreting this as a guaranteed direction for the stock price, it is prudent to use it as a data point to observe trading dynamics on the day of the ban.

📝 Editor’s Comment (by K-STOCK Editor)

This disclosure clearly illustrates how intense the supply-demand battle surrounding Alteogen has been lately. Short sellers slammed the gas pedal a bit too hard, triggering the regulatory ‘overheated’ tag and forcing a one-day short selling freeze on January 22. With short sellers blocked from entering new positions for the day, attention turns to how the remaining market demand will react. However, keep an eye on the extension clause—if the stock slips by -5% or more during the ban, the restrictions could be extended further. This commentary sketches general market vibes and does not constitute any buy or sell signals.

📢 Disclaimer & Source Information

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

🐂
BULLS
VS
🐻
BEARS

🔥 Bulls vs Bears, drop your analysis in the comments!

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Alteogen(196170) Signs Exclusive License Agreement with GSK Subsidiary for ALT-B4 Valued up to KRW 420.0B
Next Post: [Disclosure] Daeduck Electronics (353200) to Host Corporate Briefing (IR) on Feb 4 via Daishin Securities; Eyes 4Q2025 Results and Outlook

Related Posts

[Disclosure] Alteogen(196170) Reports KRW 114.7B Operating Profit for 2025… A Massive 274.8% YoY Surge Disclosures
[Disclosure] Alteogen (196170) to Acquire 1.05M New Shares of Altos Biologics Due to Subsidiary Merger, Resulting in 62.89% Stake Disclosures
[Disclosure] Alteogen (196170) Reports Q1 2026 Operating Profit of KRW 39.3B… An Explosive 100% QoQ Surge Disclosures
[Disclosure] Alteogen (196170) to Receive USD 15M (KRW 21.9B) Milestone Payment from MSD Following European Approval of Keytruda SC Disclosures
[Disclosure] Alteogen (196170) to List 40,820 Additional Common Shares Following Executive Stock Option Exercises Disclosures
[Disclosure] Alteogen (196170) Scores Huge Win: Eylea Biosimilar ‘Eyzanfy’ Secures Official MFDS Marketing Approval in South Korea Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme